Search Results 31-40 of 13544 for risksas

  1. Radiology - Doctors - Mayo Clinic

    Learn about the radiology expertise and services offered at Mayo Clinic to solve the most serious and complex medical questions for people who turn to the ...

  2. https://www.mayoclinic.org/arabic_patient_consumer_video.xml

  3. A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma - Mayo Clinic

    Selumetinib is a drug that works by blocking some enzymes that low grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs ...

  4. https://www.mayoclinic.org/spanish_patient_consumer_video.xml

  5. Long Term Follow-Up of Subjects Exposed to GSK3377794 - Mayo Clinic

    About this study. The purpose of this long-term, followup study is to evaluate subjects who have, during the interventional study, received GSK3377794 ...

  6. A Study of Gluten Intolerance in Patients with Diarrhea Predominant Irritable Bowel Syndrome - Mayo Clinic

    About this study. The purpose of this study is to test gluten supplementation for four weeks, to see if it increases small intestinal permeability and ...

  7. https://www.mayoclinic.org/chinese_patient_consumer_video.xml

  8. Study to Evaluate Chemoembolization Combined with Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma - Mayo Clinic

    Inclusion Criteria: Male and/or female. Age ≥ 18 years at the time of screening. For patients aged < 20 years and enrolled in Japan, a written informed ...

  9. Post-Operative Mobility after Operative Fixation of Geriatric Distal Femur Fractures - Mayo Clinic

    Inclusion Criteria: Patients ≥ 60 years old who sustain a low energy distal femur fracture (AO-OTA 33A-C) and can give informed consent will be included.

  10. Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With RAS Wild-Type Locally Advanced or Metastatic Colorectal Cancer That Cannot Be Removed by Surgery - Mayo Clinic

    Irinotecan may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab and bevacizumab, ...